Kimbell Royalty Partners LP buy krebskrebs
Start price
21.09.20
/
50%
€5.58
Target price
04.11.21
€7.00
Performance (%)
124.00%
End price
05.11.21
€12.49
Summary
This prediction ended on 05.11.21 with a price of €12.49. With a performance of 124.00% the BUY prediction by krebskrebs was a big success. Dividends of €1.13 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Kimbell Royalty Partners LP | -2.013% | -2.013% | 4.115% | 65.840% |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by krebskrebs for this prediction
In the thread Kimbell Royalty Partners LP diskutieren
Buy mit Kursziel 7,0
In the thread Trading Kimbell Royalty Partners LP
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten